Neuroplasticity was improved by systemic administration of ZL006 after ischemia as it could reduce excessive neural excitability by dissociating nNOS-PSD-95 complex, and then increase dendrite spine density, thereby improving neuroprotection outcome (Lin et al., 2018). The gene discussed is DLG4; the disease is ischemia.